New scan
You checked
Methylphenidate / Amphetamine derivatives
SACAA Part 67 assessment
Not acceptable / incompatible with flying duties
Active ingredient(s)
Methylphenidate / Amphetamine derivatives
CNS stimulant
Guidance notes
Central-acting stimulant — generally unacceptable. ADHD diagnosis and treatment require individual SACAA consideration.
Known SA brand names
RitalinConcertaNeuconVyvanse
Contact a professional
Our partner Buchner Med can assist with aviation medical assessments and DAME consultations. Alternatively, find an SACAA-certified DAME directly through the official list.